Variant report
Variant | esv3403851 |
---|---|
Chromosome Location | chr4:188133658-188137956 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZFP42-7 | chr4:188133530-188134139 | XLOC_003825 |
2 | lnc-ZFP42-7 | chr4:188134283-188134753 | NONHSAT099688 |
3 | lnc-ZFP42-7 | chr4:188133984-188134139 | NONHSAT099688 |
4 | lnc-ZFP42-7 | chr4:188134283-188135298 | XLOC_003825 |
5 | lnc-ZFP42-7 | chr4:188133530-188134139 | XLOC_003825 |
6 | lnc-ZFP42-7 | chr4:188134283-188134810 | XLOC_003825 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ANKRD57 | miRNA target sites |
ZFYVE26 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187982156 | chr4:188133682-188133683 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs199916580 | chr4:188133684-188133685 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs116013571 | chr4:188133685-188133686 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs192259636 | chr4:188133689-188133690 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs144995947 | chr4:188133694-188133695 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs115749856 | chr4:188133762-188133763 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs556688712 | chr4:188133763-188133764 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs573506625 | chr4:188133764-188133765 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs536095997 | chr4:188133821-188133822 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs565273452 | chr4:188133856-188133857 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs555829154 | chr4:188133866-188133867 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs67199177 | chr4:188133871-188133872 | Weak transcription Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs185744169 | chr4:188133885-188133886 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs148260535 | chr4:188133909-188133910 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs564490682 | chr4:188133917-188133918 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs558446690 | chr4:188133928-188133929 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs544133006 | chr4:188133929-188133930 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs201892886 | chr4:188133966-188133967 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs534125030 | chr4:188133989-188133990 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs75430245 | chr4:188134014-188134015 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs558864226 | chr4:188134082-188134083 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs141344844 | chr4:188134103-188134104 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs559383449 | chr4:188134118-188134119 | Weak transcription Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs184951167 | chr4:188134153-188134154 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550933027 | chr4:188134208-188134209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74570779 | chr4:188134220-188134221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570910850 | chr4:188134225-188134226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536903170 | chr4:188134241-188134242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550450029 | chr4:188134247-188134248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189465236 | chr4:188134287-188134288 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs150385419 | chr4:188134290-188134291 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs552927680 | chr4:188134320-188134321 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs373616225 | chr4:188134333-188134334 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs72719071 | chr4:188134361-188134362 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs113108849 | chr4:188134425-188134426 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs558137658 | chr4:188134428-188134429 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs372588754 | chr4:188134432-188134433 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs578077170 | chr4:188134497-188134498 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs543879664 | chr4:188134521-188134522 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs557685305 | chr4:188134525-188134526 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs7660338 | chr4:188134541-188134542 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs138022969 | chr4:188134547-188134548 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs143653086 | chr4:188134550-188134551 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs576756041 | chr4:188134602-188134603 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs147157821 | chr4:188134646-188134647 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs564678270 | chr4:188134669-188134670 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs76322873 | chr4:188134670-188134671 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs181939597 | chr4:188134743-188134744 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs567538420 | chr4:188134759-188134760 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs548961390 | chr4:188134784-188134785 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Facioscapulohumeral muscular dystrophy | 21829175 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Autism | 18414403 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 20409316 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Developmental delay | 22127048 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cervical cancer | 21063398 | CNVD |
Oral cancer | 21386901 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:188131800-188136600 | Weak transcription | Esophagus | oesophagus |
2 | chr4:188132000-188139400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr4:188133400-188134800 | Enhancers | Fetal Lung | lung |
4 | chr4:188133400-188134800 | Enhancers | Fetal Stomach | stomach |
5 | chr4:188133600-188134200 | Active TSS | Aorta | Aorta |
6 | chr4:188134200-188134600 | Enhancers | Aorta | Aorta |
7 | chr4:188134800-188139600 | Weak transcription | Fetal Lung | lung |
8 | chr4:188136200-188136600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr4:188136600-188137000 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr4:188137000-188137200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |